The present invention provides a novel phenylpropionic acid derivative and a PPAR-γ modulator comprising the same as an active ingredient. The phenylpropionic acid derivative of the present invention has modulatory action on function of PPAR-γ and then exhibits hypoglycemic, hypolipidemic and insulin resistance-reducing effects on PPAR-mediated diseases or disorders. Therefore, the present invention is prophylactically or therapeutically effective for diabetes and metabolic diseases.
本发明提供了一种新型
苯丙酸衍
生物,以及包含该衍
生物作为活性成分的
PPAR-γ调节剂。本发明的
苯丙酸衍
生物对
PPAR-γ的功能具有调节作用,从而在
PPAR介导的疾病或紊乱中表现出降糖、降脂和减少
胰岛素抵抗的效果。因此,本发明在预防或治疗糖尿病和代谢性疾病方面具有预防或治疗效果。